Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Bolka Biotechnology is a specialized biotechnology company based in Nanjing, China, focusing on DNA-encoded library (DEL) technology for drug discovery. The company provides high-throughput screening services and custom library construction to pharmaceutical and biotech partners globally. By leveraging its proprietary DEL platform, Nanjing Bolka facilitates the rapid identification of small molecule leads against a wide range of biological targets. Their expertise spans chemical synthesis, molecular biology, and bioinformatics, positioning them as a key player in the early-stage drug discovery services market. The company aims to accelerate the drug development process through innovative screening methodologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Bolka.